DK0946175T3 - Anvendelse af en kombination af H+,K+ATPase inhibitorer og glucocorticoider til behandling af nasale polypper - Google Patents

Anvendelse af en kombination af H+,K+ATPase inhibitorer og glucocorticoider til behandling af nasale polypper

Info

Publication number
DK0946175T3
DK0946175T3 DK97945135T DK97945135T DK0946175T3 DK 0946175 T3 DK0946175 T3 DK 0946175T3 DK 97945135 T DK97945135 T DK 97945135T DK 97945135 T DK97945135 T DK 97945135T DK 0946175 T3 DK0946175 T3 DK 0946175T3
Authority
DK
Denmark
Prior art keywords
glucocorticoids
combination
nasal polyps
atpase inhibitors
treat nasal
Prior art date
Application number
DK97945135T
Other languages
English (en)
Inventor
Per Lindberg
Joan Pinas-Masso
Jordi Serra-Carreras
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0946175T3 publication Critical patent/DK0946175T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DK97945135T 1996-10-11 1997-10-01 Anvendelse af en kombination af H+,K+ATPase inhibitorer og glucocorticoider til behandling af nasale polypper DK0946175T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (1)

Publication Number Publication Date
DK0946175T3 true DK0946175T3 (da) 2003-03-17

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97945135T DK0946175T3 (da) 1996-10-11 1997-10-01 Anvendelse af en kombination af H+,K+ATPase inhibitorer og glucocorticoider til behandling af nasale polypper

Country Status (33)

Country Link
EP (1) EP0946175B1 (da)
JP (1) JP4100713B2 (da)
KR (1) KR100510812B1 (da)
CN (1) CN1146416C (da)
AR (1) AR008886A1 (da)
AT (1) ATE230597T1 (da)
AU (1) AU738310B2 (da)
BR (1) BR9711896A (da)
CA (1) CA2268305C (da)
CZ (1) CZ298799B6 (da)
DE (1) DE69718347T2 (da)
DK (1) DK0946175T3 (da)
EE (1) EE04043B1 (da)
ES (1) ES2188995T3 (da)
HU (1) HUP0000036A3 (da)
ID (1) ID23692A (da)
IL (1) IL129324A0 (da)
IS (1) IS1930B (da)
MY (1) MY117918A (da)
NO (1) NO321007B1 (da)
NZ (1) NZ334786A (da)
PL (1) PL190902B1 (da)
PT (1) PT946175E (da)
RS (1) RS49599B (da)
RU (1) RU2197966C2 (da)
SA (1) SA97180641B1 (da)
SE (1) SE9603725D0 (da)
SK (1) SK284252B6 (da)
TR (1) TR199900770T2 (da)
TW (1) TW568784B (da)
UA (1) UA59374C2 (da)
WO (1) WO1998016228A1 (da)
ZA (1) ZA978842B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
ID27345A (id) 1998-08-18 2001-04-05 Univ California Pencegahan produksi lendir jalan udara dengan antagonis egf-r
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
SI1180378T1 (sl) * 1999-03-03 2011-04-29 Optinose As Nazalni aplikator
US20050020637A1 (en) * 2001-11-19 2005-01-27 Wolfgang-Alexander Simon Agents for the treatment of airway disorders
EP1487447A1 (en) * 2002-03-14 2004-12-22 ALTANA Pharma AG Use of proton pump inhibitors for the treatment of airway disorders
PL373000A1 (en) * 2002-05-07 2005-08-08 Altana Pharma Ag Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
JP2005528418A (ja) * 2002-05-07 2005-09-22 アルタナ　ファルマ　アクチエンゲゼルシャフト 気道疾患を治療するための新規組み合わせ
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
RU2252025C1 (ru) * 2003-11-28 2005-05-20 Дальневосточный государственный медицинский университет Способ лечения избыточной грануляционной ткани гортани и трахеи
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
EP0946175A1 (en) 1999-10-06
BR9711896A (pt) 1999-08-24
DE69718347D1 (de) 2003-02-13
NO991619D0 (no) 1999-04-06
IS5021A (is) 1999-04-08
RS49599B (sr) 2007-06-04
JP2001508034A (ja) 2001-06-19
HUP0000036A2 (hu) 2002-05-29
IS1930B (is) 2004-05-18
ES2188995T3 (es) 2003-07-01
NO991619L (no) 1999-04-06
AU738310B2 (en) 2001-09-13
UA59374C2 (uk) 2003-09-15
CA2268305C (en) 2006-11-28
PT946175E (pt) 2003-04-30
KR20000049046A (ko) 2000-07-25
DE69718347T2 (de) 2003-08-28
NO321007B1 (no) 2006-02-27
SA97180641B1 (ar) 2005-12-18
KR100510812B1 (ko) 2005-08-31
HU0000036D0 (da) 2002-05-29
CZ298799B6 (cs) 2008-02-06
WO1998016228A1 (en) 1998-04-23
RU2197966C2 (ru) 2003-02-10
PL332692A1 (en) 1999-09-27
AU4640997A (en) 1998-05-11
EE04043B1 (et) 2003-06-16
SK38499A3 (en) 2000-03-13
SK284252B6 (sk) 2004-12-01
AR008886A1 (es) 2000-02-23
CZ122999A3 (cs) 1999-09-15
EE9900118A (et) 1999-10-15
EP0946175B1 (en) 2003-01-08
ZA978842B (en) 1998-04-14
NZ334786A (en) 2000-12-22
CN1232397A (zh) 1999-10-20
CA2268305A1 (en) 1998-04-23
JP4100713B2 (ja) 2008-06-11
HK1022848A1 (en) 2000-08-25
MY117918A (en) 2004-08-30
CN1146416C (zh) 2004-04-21
PL190902B1 (pl) 2006-02-28
YU16399A (sh) 2000-03-21
IL129324A0 (en) 2000-02-17
SE9603725D0 (sv) 1996-10-11
ID23692A (id) 2000-05-11
TR199900770T2 (xx) 1999-06-21
ATE230597T1 (de) 2003-01-15
HUP0000036A3 (en) 2003-02-28
TW568784B (en) 2004-01-01

Similar Documents

Publication Publication Date Title
DK1109453T3 (da) Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme
DK0923585T3 (da) Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
DK0785770T3 (da) Sammensætninger til bekæmpelse af hæmorroider og fremgangsmåde til anvendelse deraf
DK0914103T3 (da) Behandling af hæmoglobinopati
NO20010231D0 (no) Fremgangsmåte til kjemisk rensing og lösningsmiddel
DK0781136T3 (da) Forbindelser og fremgangsmåder til behandling af cancer
NO20001323L (no) Dipeptid-apoptose-inhibitorer og deres anvendelse
NO991922L (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
DK0983251T3 (da) Anti-inflammatorisk piperazinylbenzyltetrazolderivater og mellemprodukter derfor
NO980015D0 (no) Nye trombininhibitorer, deres fremstilling og anvendelse
DK0815922T3 (da) Fremgangsmåde til afsvovling og decarbonisering
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
DK1089719T3 (da) Transdermalt terapeutisk system indeholdende hormoner og krystallisationsinhibitorer
DE69826282D1 (de) Handgelenkband zur vermeidung und behandlung des karpaltunnelsyndroms
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
DK0964860T3 (da) Atropisomerer af 3-heteroaryl-4-(3H)-quinazolinoner til behandling af neurodegenerative og CNS-trauma-relaterede tilstande
DK1094986T3 (da) Vandrensningssystem og fremgangsmåde
DK1381620T3 (da) Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer
DK0807605T3 (da) Anordning til afsaltning og behandling af vand
DK0776899T3 (da) Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider
DK0589832T3 (da) Fremgangsmåde og anlæg til deoxidation af vand
NO952599D0 (no) Stoppeklokke og klokkesystem
FI950809A0 (fi) Joustava suojaava membraani käytettäväksi erityisesti teräsbetonikappaleiden ja metalliputkien vedenpitäväksi tekemiseen ja suojaamiseen